Form 4 Tracker
Martine A Rothblatt

Director; Director, Chairperson & CEO · 165 filings · Latest: Oct 15, 2026

BETA Technologies, Inc.
UNITED THERAPEUTICS Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 21, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 20, 2026
Sale
$521.029,500$4.9M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 20, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 19, 2026
Sale
$526.969,500$5.0M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 19, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 18, 2026
Sale
$515.609,500$4.9M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 18, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 17, 2026
Sale
$506.599,500$4.8M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 17, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 14, 2026
Sale
$498.919,500$4.7M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 14, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 13, 2026
Sale
$504.249,500$4.8M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 13, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 12, 2026
Sale
$515.039,500$4.9M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 12, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 11, 2026
Sale
$522.879,500$5.0M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 11, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 10, 2026
Sale
$530.119,500$5.0M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 10, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 7, 2026
Sale
$531.389,500$5.0M324,443